Managers' Transactions & Directors' Dealings

Notifications of transactions by persons discharging managerial responsibilities (Managers’ Transactions) pursuant to Article 19 of the MAR, Market Abuse Regulation (EU) No 596/2014 and according to section 15a of the WpHG, German Security and Trading Act (Directors’ Dealings)

According to Article 19 of the Market Abuse Regulation RHÖN-KLINIKUM AG is obliged to announce all relevant transactions of members of the management or supervisory bodies as well as of any other persons with regular access to inside information who take important managerial decisions towards the German Federal Financial Supervisory Authority (BaFin). Those transactions comprise shares or debt instruments of RHÖN-KLINIKUM AG which are traded on the financial markets or financial instruments linked thereto (e.g. derivatives). There is no notification requirement if the total volume of all transactions for the calendar year is less than EUR 5,000.

Please find an overview of transactions conducted by persons discharging managerial responsibilities (Managers‘ Transactions) according to Article 19 MAR, which has been legally binding in Germany since July 3, 2016 as well as transactions pursuant to § 15a WpHG (Directors’ Dealings), published previously, here.